Replies to post #150 on Cardiol Therapeutics Inc (CRDL)

[Sirpeter]

Welcome to the Cardiol Therapeutics hotel...our guests sleep well here

[MahinAgency]

NASDAQ: $CRDL SHORT SQUEEZE ALERTS

H.C. Wainwright maintains a "Buy" rating for Cardiol Therapeutics with a price target of $9.00.

MAVERIC-2 trial aims to assess CardiolRx in recurrent pericarditis patients post-IL-1 blocker therapy.